Skip to content

FTSE 100 at the close: Standard Chartered, Persimmon, GSK

FTSE 100 at the close: Standard Chartered, Persimmon, GSK

By Patrick Munnelly, Market Analyst, Tickmill

The FTSE 100 is struggling for a second successive session. Investors seemed spooked by banking concerns Stateside with First Republic Bank shares getting slashed again, repeatedly hitting circuit breakers as the shares, already down 90%, have shed a further 50% during Tuesday’s New York session. The index fell 38 points to end the day at 7852.64.


FTSE100 biggest movers

Bucking the banking crisis concerns, UK independent bank Standard Chartered LON:STAN put in stellar earnings with pre tax profits surging by 21% smashing expectations and leading to a 2.1%+ day in the green.

The counter intuitive trade of the day has been homebuilder Persimmon LON:PSN, who announced a 42% drop in new home completions. However, investors took solace from a trading update that suggests there has been incremental improvement since the beginning of 2023. This led to investors support for the stock with the shares popping 4.9% on the day. The upbeat guidance from Persimmon saw support for bedfellows Taylor Wimpey LON:TW. +4.1% and Barratt Developments LON:BDEV up 2.9%+.

On the negative side of the ledger GSK LON:GSK reported an adjusted profit of 37p per share on revenue of £7 billion which marginally exceeded estimates. However, GSK CEO Emma Walmsley has raised concerns regarding a review of EU pharma legislation. This may see pharma firms forced to reallocate investment to alternative jurisdictions. The note of caution led investors to reduce exposure as the shares shed 3.9%.

Spirax-Sarco Engineering LON:SPX sits at the foot of the FTSE today, shedding just over 5%, given investor concerns regarding return on equity, elevated profit retention and future growth opportunities.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.
Join our UK news channel on WhatsApp

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

TMX
WisdomTree
ARK
FxPro
CMC Markets
Back To Top